| Document |
Document Title |
|
WO/2016/210112A1 |
Methods, compositions, kits, and drug delivery devices are provided for treating, adhering, or sealing biological tissues. The methods include combining a first solution that includes an oligomer/polymer component and a second solution t...
|
|
WO/2016/202984A1 |
A composition with improved adhesive and sealant properties comprises a) a pre-polymer comprising a polymeric unit of the general formula (-A-B-)n, wherein A represents a substituted or un-substituted ester, B represents a substituted or...
|
|
WO/2016/190400A1 |
A hydrogel which adheres to surfaces of materials is provided by using, as constituent elements, a water-soluble main-chain monomer, a crosslinking agent, a polymerization initiator, and an adhesive monomer having at least a catechol gro...
|
|
WO/2016/189266A1 |
A sterilized sachet (1) comprises a sealed impervious pouch (2) containing a biocide (4). The pouch (2) but not the biocide (4) has been sterilized by irradiation prior to having been filled with the biocide (4) and sealed. Preferably, t...
|
|
WO/2016/185214A1 |
The invention provides a device for application to the skin of a patient to facilitate intravenous access, e.g. via needles, syringes, cannulas or catheters, the device having an upper surface and a lower surface, wherein the lower surfa...
|
|
WO/2016/181137A1 |
A sterile, ready-to-use, flowable haemostatic composition comprises a soluble haemostatic agent comprising a plurality of carriers and a plurality of fibrinogen binding peptides immobilised to the carrier; a biocompatible liquid; and par...
|
|
WO/2016/178829A1 |
Provided is a chitosan based hemostatic formulation comprising carboxymethyi chitosan, and methyl cellulose. More particularly, provided is a chitosan based hemostatic formulation comprising carboxymethyi. chitosan, methyl cellulose, hyd...
|
|
WO/2016/174104A1 |
The present invention relates to bacterial nanocellulose composite which comprises nanocellulose, sensor or signal processing molecule(s), actuator/effector molecule(s) and/or cells and optionally further component(s). The present invent...
|
|
WO/2016/176186A1 |
A hemostatic composition comprises calcium alginate, a chitosan, epsilon-aminocaproic acid, an acid selected from aminomethylbenzoic acid and tranexamic acid, and tannin. The method of making the hemostatic composition comprises mixing o...
|
|
WO/2016/171633A1 |
In present invention oxidation method of viscon cellulose with NO2 obtained H3PO4/HNO3 is defined liquid and gas media. Regenerated oxidise cellulose (REOC in shorten term) contain in -COOH yields are standardised as 18.6 - 20.1 for text...
|
|
WO/2016/166220A1 |
Subject of the invention is a composition comprising: (a) at least one film-forming polymer, which does not comprise silicon, (b) at least one organic UV filter, and (c) at least one organic solvent, wherein the composition is liquid at ...
|
|
WO/2016/164315A1 |
Film forming gel compositions, useful in creating conformable and flexible gel bandages, can be formulate from a film-forming polymer, a tackifier, and a volatile solvent. The film forming gels can also include antiseptics, cationic poly...
|
|
WO/2016/139322A1 |
The invention provides a self-assembled microparticle having an acid having two or more acid groups and an organic base in a solvent. The microparticles may form into a macrostructure and provide a scaffold for cell culture. The particle...
|
|
WO/2016/135219A1 |
Topical composition for the treatment of mucosal lesions It relates to a topical composition comprising specific amounts of: a) a hyaluronic acid or a pharmaceutically or veterinary acceptable salt thereof, b) one or more adhesive agents...
|
|
WO/2016/133483A1 |
The hemostatic composition, comprising water-retaining, binder dust suppression, inorganic and organic hemostatic agents, and hemostatic device comprising the composition of hemostatic agents and a container that keeps hemostatic composi...
|
|
WO/2016/128916A1 |
Described herein are compositions of collagen and micronized placental tissue components, methods for producing the same and methods for using the same for wound healing, repairing damaged tendons, cosmetic applications and covering bioc...
|
|
WO/2016/118871A1 |
This disclosure provides novel hydrogels that can undergo multiple gel-sol transitions and methods of making and using such hydrogels, particularly in anastomosis procedures. The peptide hydrogels comprising a fibrillar network of peptid...
|
|
WO/2016/100861A1 |
The present disclosure relates, in general, to hemostatic compositions comprising polysaccharide based polymers, such as amylopectins, amylose, dextrins, maltodextrins and icodextrin and modified forms thereof, cross-linked with a cross-...
|
|
WO/2016/089731A1 |
Compositions for treating a biofilm comprising viable microorganisms are provided. The compositions include a suspending medium, a bioactive glass comprising B2O3, and an effective amount of an antimicrobial compound selected from the gr...
|
|
WO/2016/081820A1 |
Described herein are compositions of alginate formulations and their use for treating incisional wounds, such as intra-incisional application.
|
|
WO/2016/079006A1 |
This invention relates to a method for sealing dentinal tubules exposed at the tooth surface as a consequence of enamel defects, based on amorphous calcium polyphosphate (Ca-polyP) nano- or microparticles that strongly bind both to tooth...
|
|
WO/2016/066784A1 |
The present invention provides cyclic antimicrobial pseudopeptides that are useful in a variety of applications. Also provided are pharmaceutical compositions, products and kits comprising such cyclic antimicrobial peptides and methods o...
|
|
WO/2016/064340A1 |
The invention is a class of spray-on burn dressings for use in the treatment of various types of tissue burns, such as burns due to heat, chemicals, or sun exposure. The inventive spray-on dressing is comprised of a film-forming polymer ...
|
|
WO/2016/058612A1 |
The present disclosure relates to a dry composition which reconstitutes without mechanical mixing to form a flowable paste having a soft and light consistency suitable for use in haemostasis and wound healing procedures upon addition of ...
|
|
WO/2016/042471A1 |
The present invention relates to a material comprising or consisting in chitin nanofibrils, lignin and at least a co-polymer, as well as to a process for the preparation thereof. Furthermore, the present invention relates to biomedical a...
|
|
WO/2016/042474A1 |
The present invention relates to a material comprising or consisting in chitin nanofibrils, lignin and at least a co-polymer, as well as to a process for the preparation thereof. Furthermore, the present invention relates to biomedical a...
|
|
WO/2016/042483A1 |
The present invention relates to a consumer good product comprising: (a) a composition comprising or consisting of a mixture of: (i) chitin nanofibrils; (ii) lignin or a derivative thereof; and (iii) optionally, at least one polymer or c...
|
|
WO/2016/040385A1 |
Described herein are compositions composed of micronized placental components and optionally a sealant, and pharmaceutical compositions thereof. Also described are systems, apparatuses, and methods for applying the combination of microni...
|
|
WO/2016/036330A1 |
The present invention relates to a repairing layer which covers at least a part of wound upon being applied inside or onto a wound and comprises water, ozonized oil, glycerol and astragalus plant extract.
|
|
WO/2016/020861A2 |
The present solution relates to film or sponge compositions, and to a method for producing the same for the prevention and treatment of urogenital infections, in particular vaginal infections. A water-based composition for producing a fi...
|
|
WO/2016/020774A1 |
The present invention refers to elastomeric compositions useful for making and/or coating medicated devices. The invention also refers to such medicated devices, and a process for making and using thereof.
|
|
WO/2016/018145A1 |
This invention relates to new injectable hydrogel materials that consist of water gellants comprising linear hydrophilic polymers that comprise hydrogen bonding units in the backbone combined with cross-linkable end groups, resulting if ...
|
|
WO/2016/007692A1 |
A hydrogel composition from a cross-linked polymer derived from one or more olefinically unsaturated polymerizable carboxylic monomers and a thermoplastic polyurethane composition is disclosed. The hydrogel exhibits high yield stress at ...
|
|
WO/2015/189389A1 |
The invention relates to a wound contact material for use in the treatment and/or care of a wound, in particular a chronic wound, of a human or animal, wherein the wound contact material is capable of releasing lactic acid and/or lactate...
|
|
WO/2015/179235A1 |
A discontinuous silicone article is disclosed that includes a plurality of strands of radiation cured silicone gel arranged to form a net-like structure with openings between strands. The silicone gel provides adhesion to a surface, such...
|
|
WO/2015/162523A1 |
The present invention relates to a method of synthesis and the use of foamed, cross-linked polyurethane polymers, as a three-dimensional support called a "scaffold" for cell cultures in vitro and for in vivo implantation for the regenera...
|
|
WO/2015/150705A1 |
The invention relates to a film-forming liquid composition comprising a film-forming polymer derived from polyurethane present in the composition in a dry matter content of between 25 and 60 wt. % in relation to the total weight of the c...
|
|
WO/2015/140563A1 |
The present invention relates to a wound dressing composition that is capable of gelling upon contact with a fluid derived from a human or animal body, and which is able to maintain the integrity of the gel for a period of time that is l...
|
|
WO/2015/138478A1 |
Materials and methods for treatment of pulmonary bulla are provided. A peptide comprising between about 7 amino acids and about 32 amino acids in a solution may be introduced to a target site. A hydrogel barrier may be provided at the ta...
|
|
WO/2015/138475A1 |
Materials and methods for forming a bronchial obstruction are provided. A peptide comprising between about 7 amino acids and about 32 amino acids in a solution may be introduced to a target site. A hydrogel barrier may be provided at the...
|
|
WO/2015/138473A1 |
Materials and methods for treatment of pulmonary leakage are provided. A peptide comprising between about 7 amino acids and about 32 amino acids in a solution may be introduced to a target site. A hydrogel barrier may be provided at the ...
|
|
WO/2015/125047A1 |
The present invention relates to fractions of extracts of Helichrysum having mucoadhesive and barrier effect properties, compositions comprising said fractions, their uses and methods for the preparation of said fractions and said compos...
|
|
WO/2015/123383A1 |
The present invention provides methods for promoting wound healing or treating dermal radiation injury by the use of a gel formulation comprising about 0,5% to about 4% hydroxyethyl cellulose (HEC) on a weight (mg)/volume (ml) basis, or ...
|
|
WO/2015/116888A1 |
An oxygen catalyst-containing structure comprising a first layer encapsulated by a second layer is provided, where the first layer includes an oxygen catalyst and the second layer is free of an oxygen catalyst. A method of making an oxyg...
|
|
WO/2015/070233A9 |
Ultra-low crosslinked microgels made of an ultra-low crosslinked polymer are provided. The microgels, also referred to as Platelet-like Particles (PLPs), preferably have <0.5% crosslinking densities. One or more of the polymers are conju...
|
|
WO/2015/092315A1 |
The present invention relates to a composite material for filling a wound, which includes a shell containing a material or a group of materials forming fluid flow channels, said shell consisting of a self-supporting interface material fo...
|
|
WO/2015/086028A1 |
Disclosed is a dry composition comprising one or more polyols, which upon addition of an aqueous medium forms a substantially homogenous paste suitable for use in haemostasis procedures. The paste reconstitutes spontaneously upon additio...
|
|
WO/2015/086640A1 |
The present invention relates to methods for adhering tissue surfaces and materials and biomedical uses thereof. In particular the present invention relates to a method for adhering a first tissue surface to a second tissue surface in a ...
|
|
WO/2015/088275A1 |
The present invention provides a biodegradable medical adhesive or a sealant composition containing an oxidized glycosaminoglycan and a polyamine. The composition of the present invention exhibits improved effects in biodegradation, coat...
|
|
WO/2015/076252A1 |
This tissue adhesive porous film (1) is a film having a porous structure in which hydrophobized gelatin (10) is crosslinked, wherein the hydrophobized gelatin (10) is gelatin (13) in which a part of an amino group (12) of Lys is substitu...
|
